Sébastien Uzel

Sébastien Uzel is the Scientific Director and Head of Innovation at TreeFrog Therapeutics, focusing on cell therapy and biomanufacturing. An alumnus of MIT, his background includes leading research at Harvards Wyss Institute, where he co-developed a breakthrough 3D bioprinting technique. Colleagues have described him as a hard-working and friendly team member.

Based on his extensive academic and professional history in the Boston area, including his PhD at MIT and research at Harvard, Sébastien has deep roots in the Cambridge/Boston innovation ecosystem. He is currently expanding his companys presence by hiring for its Boston office.

Unique fact: He co-developed the SWIFT (sacrificial writing into functional tissue) 3D bioprinting method, a major advance for creating vascular networks in engineered tissues.